Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

Researcher find an emergent SARS-CoV-2 variant in California

Researchers have found a new SARS-CoV-2 variant in California, USA. This variant is more transmissible than circulating strains but slightly less transmissible than the new N501Y variant and moderately resistant to antibodies in convalescent sera and mRNA vaccines.

10 Mar 2021

Researchers characterize antibody responses to COVID-19 mRNA-based vaccine

A team of scientists from the USA and Canada has recently characterized the antibodies developed against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in response to an mRNA-based coronavirus disease 2019 (COVID-19) vaccine.

10 Mar 2021

Researchers study prevalence of SARS-CoV-2 UK variant at University of Texas

Researchers at the University of Texas at Austin and Santa Fe Institute in the US used quantitative polymerase chain reaction (PCR) data from a surveillance testing program on a large university campus to estimate how fast the new variant spreads. The team used the data to provide local situational information on the COVID-19 pandemic.

10 Mar 2021

SARS-CoV-2 UK variant could soon be dominant in Switzerland

Researchers at the Swiss Institute of Bioinformatics estimate that the B.1.1.7 variant may be dominant in Switzerland by March.

10 Mar 2021

QCMD to use RNAssist’s virusPHIX-P9™ Biomolecule Stabilization Technology in its SARS-CoV-2 antigen EQA scheme

In a further development of the collaboration between QCMD and RNAssist, QCMD will use the universal biological sample stabilization virusPHIX-P9™.

From Rapid Labs Ltd 10 Mar 2021

What childhood vaccine rates can, and can’t, teach us about Covid vaccines

Polls show Americans are increasingly interested in getting vaccinated against Covid-19, but such surveys are largely national, leaving a big question: When the vaccines become available to the general public, will enough people get it in your county, city or neighborhood to keep your community safe?

10 Mar 2021

Texas winter storm exposes gaps in senior living oversight

When the big, red and extremely loud fire alarm went off in Maria Skladzien's apartment, the 74-year-old ventured into the hallway with fellow residents of her Houston-area senior living community.

10 Mar 2021

Pfizer’s newest vaccine plant has persistent mold issues, history of recalls

Pfizer's management knew last year there was "a mold issue" at the Kansas facility now slated to produce the drugmaker's urgently needed covid-19 vaccine, according to a Food and Drug Administration inspection report.

10 Mar 2021

For Covid ‘long haulers,’ battling for disability benefits adds aggravation to exhaustion

Rickie Andersen took a brief break from work in March after she fell ill. Her cough, fever and chills were typical covid-19 symptoms, but coronavirus tests were so scarce she could not obtain one to confirm the diagnosis.

10 Mar 2021

Single mRNA vaccine dose may be enough for those previously exposed to SARS-CoV-2

New research supports the notion that those who have recovered from COVID-19, caused by SARS-CoV-2 infection, may only need one dose of an mRNA vaccine to boost immunity.

10 Mar 2021

Neutralizing antibodies may be evolving to keep up with SARS-CoV-2 mutations

Viruses evolve under increased pressure, and new research from The Rockefeller University and University of Massachusetts Medical School in the U.S. suggests our antibodies can as well.

10 Mar 2021

mRNA COVID-19 vaccines show high efficacy in pregnancy and lactation

A reassuring study reports the immunogenicity and lack of reactogenicity of the coronavirus disease 2019 (COVID-19) vaccine when given to this group of subjects. This will contribute to the sum of knowledge about the implications of vaccination in this high-risk cohort.

10 Mar 2021

How likely is SARS-CoV-2 reinfection?

The coronavirus disease 2019 (COVID-19) pandemic has already caused over 117.6 million confirmed cases the world over. Yet, researchers debate the exact incidence of reinfection with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), COVID-19’s causative pathogen.

10 Mar 2021

Pfizer COVID-19 vaccine elicits antibodies in blood and breastmilk simultaneously, finds study

A new study adds to the sum of knowledge around this issue, showing a highly synchronized and rapid development of an antibody response in breast milk and serum, which reached stable levels around two weeks after the second dose of the vaccine was administered.

10 Mar 2021

Study: COVID-19 pandemic can affect mothers and infants through immune pathways

If past natural disasters have taught us anything about their effects on pregnant women and developing babies, it is to pay close attention, for the added stress will surely have an impact on them.

10 Mar 2021

Tiny antibodies naturally generated by llamas can be effective against COVID-19

As the fight against COVID-19 continues, scientists have turned to an unlikely source for a potentially effective treatment: tiny antibodies naturally generated by llamas.

10 Mar 2021

COVID-19 pandemic caused changes in people’s physical activity levels and wellbeing

According to an international study published in Frontiers in Psychology, people around the world have reported changes in their physical activity levels, wellbeing, and eating habits during the first stages of the COVID-19 pandemic.

10 Mar 2021

Survey shows that 43% of respondents have already tested for coronavirus

According to the current BfR-Corona-Monitor of the German Federal Institute for Risk Assessment (BfR), 43 percent of the respondents have already had themselves tested for the virus.

10 Mar 2021

New SARS-CoV-2 vaccine candidate produces strong immune response, prevents SARS-CoV-2 infection

A new SARS-CoV-2 vaccine candidate, developed by giving a key protein's gene a ride into the body while encased in a measles vaccine, has been shown to produce a strong immune response and prevent SARS-CoV-2 infection and lung disease in multiple animal studies.

10 Mar 2021